Abstract
Salivary gland carcinomas of the larynx are uncommon. Adenoid cystic carcinoma is the most prevalent type of salivary gland carcinoma in this region, although other histologies such as mucoepidermoid carcinoma and adenocarcinomas have been reported. These tumors may present with advanced-stage due to nonspecific symptoms and their relatively slow-growing nature. The index of suspicion for a non-squamous cell carcinoma entity should be high when a submucosal mass is present. An accurate diagnosis is mandatory due to the impact each biologic entity has on treatment and outcome. Data concerning treatment and outcome are scarce, but primary surgery with utmost focus on free surgical margins is the treatment of choice. The role of adjuvant radiotherapy has not been well defined, although there is an agreement that it should be considered in advanced-stage or high-grade disease. This review considers only the most common malignant salivary neoplasms of the larynx with a focus on clinical management of these tumors.
Similar content being viewed by others
References
Ferlito A, Thompson LD, Cardesa A, et al. The importance of histological types for treatment and prognosis in laryngeal cancer. Eur Arch Otorhinolaryngol. 2013;270:401–3.
Ferlito A, Takes RP, Rinaldo A, Devaney KO. Which is the single most important factor in deciding the management and determining the prognosis of head and neck cancer? Eur Arch Otorhinolaryngol. 2010;267:325–6.
Walte V, Yin X, Wilkerson MD, et al. Molecular subtypes in head and neck cancer exhibit distinct patterns of chromosomal gain and loss of canonical cancer genes. PLoS ONE. 2013;8:e56823.
El-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ, editors. WHO classification of head and neck tumours. 4th ed. Lyon: IARC; 2017.
Ferlito A, Coca-Pelaz A, Rodrigo JP, et al. New tumor phenotypes reported in the larynx in the last decades: a critique. Am J Otolaryngol. 2015;36:494–7.
Dubal PM, Svider PF, Folbe AJ, et al. Laryngeal adenoid cystic carcinoma: a population-based perspective. Laryngoscope. 2015;125:2485–90.
Nielsen TK, Bjørndal K, Krogdahl A, et al. Salivary gland carcinomas of the larynx: a national study in Denmark. Auris Nasus Larynx. 2012;39:611–4.
Coca-Pelaz A, Barnes L, Rinaldo A, et al. Cervical lymph node metastasis in adenoid cystic carcinoma of the larynx: a collective international review. Adv Ther. 2016;33:553–79.
Moukarbel RV, Goldstein DP, O’Sullivan B, et al. Adenoid cystic carcinoma of the larynx: a 40-year experience. Head Neck. 2008;30:919–24.
Marchiano E, Chin OY, Fang CH, Park RC, Baredes S, Eloy JA. Laryngeal adenoid cystic carcinoma: a systematic review. Otolaryngol Head Neck Surg. 2016;154:433–9.
Liu W, Chen X. Adenoid cystic carcinoma of the larynx: a report of six cases with review of the literature. Acta Otolaryngol. 2015;135:489–93.
Javadi M, Bafrouee FM, Mohseni M, Asghari A. Laryngeal adenoid cystic carcinoma in a child: a case report. Ear Nose Throat J. 2002;81:34–5.
Olofsson J, van Nostrand AWP. Adenoid cystic carcinoma of the larynx. A report of four cases and a review of the literature. Cancer. 1977;40:1307–13.
Ganly I, Patel SG, Coleman M, Ghossein R, Carlson D, Shah JP. Malignant minor salivary gland tumors of the larynx. Arch Otolaryngol Head Neck Surg. 2006;132:767–70.
Misiukiewicz KJ, Camille N, Tishler R, Haddad R, Limaye S, Posner M. Organ preservation for adenoid cystic carcinoma of the larynx. Oncologist. 2013;18:579–83.
Lee LA, Fang TJ, Li HY, Lee KF. Adenoid cystic carcinoma of the supraglottis mimicking a laryngeal cyst. Otolaryngol Head Neck Surg. 2003;129:157–8.
Calzada AP, Miller M, Lai CK, Elashoff DA, Abemayor E, St John MA. Adenoid cystic carcinoma of the airway: a 30-year review at one institution. Am J Otolaryngol. 2012;33:226–31.
Van Weert S, Van der Waal I, Witte B, Leemans CR, Bloemena E. Histopathologic grading of adenoid-cystic carcinoma of the head and neck: analysis of the currently used grading systems and proposal for a simplified grading scheme. Oral Oncol. 2015;51:71–6.
Perzin KH, Gullane P, Clairmont AC. Adenoid cystic carcinoma in the salivary glands: a correlation of histologic features and clinical course. Cancer. 1978;42:265–82.
Morice WG, Ferreiro JA. Distinction of basaloid squamous cell carcinoma from adenoid cystic and small cell undifferentiated carcinoma by immunohistochemistry. Hum Pathol. 1998;29:609–12.
Nascimento AG, Amaral AL, Prado LA, Kligerman J, Silveira TR. Adenoid cystic carcinoma of salivary glands. A study of 61 cases with clinicopathologic correlation. Cancer. 1986;57:312–9.
Klijanienko J, el-Naggar A, Ponzio-Prion A, Marandas P, Micheau C, Caillaud JM. Basaloid squamous carcinoma of the head and neck. Immunohistochemical comparison with adenoid cystic carcinoma and squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 1993;119:887–90.
Emanuel P, Wang B, Wu M, Burstein DE. p63 Immunohistochemistry in the distinction of adenoid cystic carcinoma from basaloid squamous cell carcinoma. Mod Pathol. 2005;18:645–50.
Tsubochi H, Suzuki T, Suzuki S, et al. Immunohistochemical study of basaloid squamous cell carcinoma, adenoid cystic and mucoepidermoid carcinoma in the upper aerodigestive tract. Anticancer Res. 2000;20:1205–11.
Mino M, Pilch BZ, Faquin WC. Expression of KIT (CD117) in neoplasms of the head and neck: an ancillary marker for adenoid cystic carcinoma. Mod Pathol. 2003;16:1224–31.
Persson M, Andrén Y, Mark J, Horlings HM, Persson F, Stenman G. Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck. Proc Natl Acad Sci USA. 2009;106:18740–4.
Stenman G, Andersson MK, Andrén Y. New tricks from an old oncogene: gene fusion and copy number alterations of MYB in human cancer. Cell Cycle. 2010;9:2986–95.
West RB, Kong C, Clarke N, et al. MYB expression and translocation in adenoid cystic carcinomas and other salivary gland tumors with clinicopathologic correlation. Am J Surg Pathol. 2011;35:92–9.
Alavi S, Namazie A, Calcaterra TC, Blackwell KE. Glandular carcinoma of the larynx: the UCLA experience. Ann Otol Rhinol Laryngol. 1999;108:485–9.
Ferlito A, Barnes L, Myers EN. Neck dissection for laryngeal adenoid cystic carcinoma: is it indicated? Ann Otol Rhinol Laryngol. 1990;99:277–80.
Hellquist H, Skálová A, Barnes L, et al. Cervical lymph node metastasis in high-grade transformation of head and neck adenoid cystic carcinoma: a collective international review. Adv Ther. 2016;33:357–68.
Seethala RR, Hunt JL, Baloch ZW, Livolsi VA, Barnes EL. Adenoid cystic carcinoma with high-grade transformation: a report of 11 cases and a review of the literature. Am J Surg Pathol. 2007;31:1683–94.
Chen AM, Bucci MK, Weinberg V, et al. Adenoid cystic carcinoma of the head and neck treated by surgery with or without postoperative radiation therapy: prognostic features of recurrence. Int J Radiat Oncol Biol Phys. 2006;66:152–9.
Mendenhall WM, Morris CG, Amdur RJ, Werning JW, Hinerman RW, Villaret DB. Radiotherapy alone or combined with surgery for adenoid cystic carcinoma of the head and neck. Head Neck. 2004;26:154–62.
Haddad RI, Posner MR, Busse PM, et al. Chemoradiotherapy for adenoid cystic carcinoma: preliminary results of an organ sparing approach. Am J Clin Oncol. 2006;29:153–7.
Laurie SA, Licitra L. Systemic therapy in the palliative management of advanced salivary gland cancers. J Clin Oncol. 2006;24:2673–8.
Bhattasali O, Holliday E, Kies MS, et al. Definitive proton radiation therapy and concurrent cisplatin for unresectable head and neck adenoid cystic carcinoma: a series of 9 cases and a critical review of the literature. Head Neck. 2016;38:E1472–80.
Goyal G, Mehdi SA, Ganti AK. Salivary gland cancers: biology and systemic therapy. Oncology (Williston Park). 2015;29:773–80.
Jaso J, Malhotra R. Adenoid cystic carcinoma. Arch Pathol Lab Med. 2011;135:511–5.
Mahlstedt K, Ussmüller J, Donath K. Malignant sialogenic tumours of the larynx. J Laryngol Otol. 2002;116:119–22.
Nance MA, Seethala RR, Wang Y, et al. Treatment and survival outcomes based on histologic grading in patients with head and neck mucoepidermoid. Cancer. 2008;113:2082–9.
Cumberworth VL, Narula A, MacLennan KA, Bradley PJ. Mucoepidermoid carcinoma of the larynx. J Laryngol Otol. 1989;103:420–3.
Mitchell DB, Humphreys S, Kearns DB. Mucoepidermoid carcinoma of the larynx in a child. Int J Pediatr Otorhinolaryngol. 1988;15:211–5.
Gomes V, Costarelli L, Cimino G, Magaldi L, Bisceglia M. Mucoepidermoid carcinoma of the larynx. Eur Arch Otorhinolaryngol. 1990;248:31–4.
Ferlito A, Recher G, Bottin R. Mucoepidermoid carcinoma of the larynx. A clinicopathological study of 11 cases with review of the literature. J Otorhinolaryngol Relat Spec. 1981;43:280–99.
King W, Ko S, Miller D. Recurrent high-grade invasive mucoepidermoid carcinoma of larynx: a case report and review of the literature. Rare Tumors. 2016;8:6204.
Seethala RR. An update on grading of salivary gland carcinomas. Head Neck Pathol. 2009;3:69–77.
Batsakis JG, Luna MA. Histopathologic grading of salivary gland neoplasms: i. Mucoepidermoid carcinomas. Ann Otol Rhinol Laryngol. 1990;99:835–8.
Nagao T. “Dedifferentiation” and high-grade transformation in salivary gland carcinomas. Head Neck Pathol. 2013;1:37–47.
Behboudi A, Enlund F, Winnes M, et al. Molecular classification of mucoepidermoid carcinomas- prognostic significance of the MECT1-MAML2 fusion oncogene. Genes Chromosomes Cancer. 2006;45:470–81.
Okabe M, Miyabe S, Nagatsuka H, et al. MECT1-MAML2 fusion transcript defines a favourable subset of muscoepidermoid carcinoma. Clin Cancer Res. 2006;12:3902–7.
Coca-Pelaz A, Rodrigo JP, Triantafyllou A, et al. Salivary mucoepidermoid carcinoma revisited. Eur Arch Otorhinolaryngol. 2015;272:799–819.
Saade RE, Bell D, Garcia J, Roberts D, Weber R. Role of CRTC1/MAML2 translocation in the prognosis and clinical outcomes of mucoepidermoid carcinoma. JAMA Otolaryngol Head Neck Surg. 2016;142:234–40.
Seethala RR, Dacic S, Cieply K, Kelly LM, Nikiforova MN. A reappraisal of the MECT1/MAML2 translocation in salivary mucoepidermoid carcinomas. Am J Surg Pathol. 2010;34:1106–21.
Sobral AP, Loducca SV, Kowalski LP, et al. Immunohistochemical distinction of high-grade mucoepidermoid carcinoma and epidermoid carcinoma of the parotid region. Oral Oncol. 2002;38:437–40.
Mahomed F. Recent advances in mucin immunohistochemistry in salivary gland tumors and head and neck squamous cell carcinoma. Oral Oncol. 2011;47:797–803.
Chenevert J, Barnes LE, Chiosea SI. Mucoepidermoid carcinoma: a five-decade journey. Virchows Arch. 2011;458:133–40.
Martinez-Madrigal F, Baden E, Casiraghi O, Micheau C. Oral and pharyngeal adenosquamous carcinoma. A report of four cases with immunohislochemical studies. Eur Arch Otorhinolaryngol. 1991;248:255–8.
Mokhtari S, Mokhtari S. Clinical features and differential diagnoses in laryngeal mucoepidermoid carcinoma. Clin Med Insights Pathol. 2012;5:1–6.
Prgomet D, Bilic M, Bumber Z, Manojlovic S, Katic V. Mucoepidermoid carcinoma of the larynx: report of three cases. J Laryngol Otol. 2003;117:998–1000.
Mokhtari S, Mokhtari S. Clinical features and differential diagnoses in laryngeal mucoepidermoid carcinoma. Clin Med Insights Pathol. 2012;5:1–6.
Wang MC, Liu CY, Li WY, Chang SY, Chu PY. Salivary gland carcinoma of the larynx. J Chin Med Assoc. 2006;69:322–5.
Sakai O, Curtin HD, Romo LV, Som PM. Lymph node pathology. Benign, proliferative, lymphoma, and metastatic disease. Radiol Clin North Am. 2000;38:979–98.
Luna-Ortiz K, Cano-Valdez AM, Chacón AP, Gómez AH. Horizontal partial laryngectomy in mucoepidermoid carcinoma of the larynx after failure of laser surgery followed by radiotherapy: a case report. Cases J. 2009;2:8421.
Ferlito A, Rinaldo A, Devaney KO, Carbone A. Management of the clinically negative cervical lymph nodes in patients with non-conventional squamous carcinoma of the larynx. J Laryngol Otol. 1999;113:619–23.
Walvekar RR, Andrade Filho PA, Seethala RR, et al. Clinicopathologic features as stronger prognostic factors than histology or grade in risk stratification of primary parotid malignancies. Head Neck. 2011;33:225–31.
Rapidis AD, Givalos N, Gakiopoulou H, et al. Mucoepidermoid carcinoma of the salivary glands. Review of the literature and clinicopathological analysis of 18 patients. Oral Oncol. 2007;43:130–6.
Pires FR, de Almeida OP, de Araújo VC, Kowalski LR. Prognostic factors in head and neck mucoepidermoid carcinoma. Arch Otolaryngol Head Neck Surg. 2004;130:174–80.
Kolokythas A, Connor S, Kimgsoo D, Fernandes RP, Ord RA. Low-grade mucoepidermoid carcinoma of the intraoral minor salivary glands with cervical metastasis: report of 2 cases and review of the literature. J Oral Maxillofac Surg. 2010;68:1396–9.
Chiosea SI, Barnes EL, Lai SY, et al. Mucoepidermoid carcinoma of upper aerodigestive tract: clinicopathologic study of 78 cases with immunohistochemical analysis of dicer expression. Virchows Arch. 2008;452:629–35.
Ozawa H, Tomita T, Sakamoto K, et al. Mucoepidermoid carcinoma of the head and neck: clinical analysis of 43 patients. Jpn J Clin Oncol. 2008;38:414–8.
Chin CH, Huang CC, Lin MC, Chao TY, Liu SF. Prognostic factors of tracheobronchial mucoepidermoid carcinoma-15 years experience. Respirology. 2008;13:275–80.
Spinazzi EF, Abboud MT, Dubal PM, et al. Laryngeal adenocarcinoma not otherwise specified: a population-based perspective. Laryngoscope. 2017;127:424–9.
Projetti F, Lacroix-Triki M, Serrano E, et al. A comparative immunohistochemistry study of diagnostic tools in salivary gland tumors: usefulness of mammaglobin, gross cystic disease fluid protein 15, and p63 cytoplasmic staining for the diagnosis of mammary analog secretory carcinoma? J Oral Pathol Med. 2015;44:244–51.
Incandela S, Aragona F, Di Marco G. The adenocarcinoma of the larynx: in aim of a clinic case. Histologic, immuno-histochemistry and electron microscope studies. Rev Laryngol Otol Rhinol (Bord). 1999;120:35–8.
Bayram I, Ugras S, Kiris M, Recber D. Adenocarcinoma of the larynx: a case report with histochemical and immunohistochemical studies. Kulak Burun Bogaz Ihtis Derg. 2004;13:41–5.
Luna MA. Salivary gland neoplasms. In: Ferlito A, editor. Surgical pathology of laryngeal neoplasms. London: Chapman and Hall; 1996. p. 258–94.
Hilger AW, Prichard AJ, Jones T. Adenocarcinoma of the larynx-a distant metastasis from a rectal primary. J Laryngol Otol. 1998;112:199–201.
Karatayli-Ozgursoy S, Bishop JA, Hillel AT, Akst LM, Best SR. Malignant salivary gland tumours of the larynx: a single institution review. Acta Otorhinolaryngol Ital. 2016;36:289–94.
Acknowledgements
No funding or sponsorship was received for this study or publication of this article. All named authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship for this manuscript, take responsibility for the integrity of the work as a whole, and have given final approval for the version to be published. This article was written by members of the International Head and Neck Scientific Group (www.IHNSG.com).
Disclosures
Fernando López, Michelle D. Williams, Alena Skálová, Henrik Hellquist, Carlos Suárez, Iain J Nixon, Juan P Rodrigo, Antonio Cardesa, Primož Strojan, Miquel Quer, Jennifer L. Hunt, Alessandra Rinaldo, and Alfio Ferlito have nothing to disclose.
Compliance with Ethics Guidelines
This article is based on previously conducted studies and does not involve any new studies of human or animal subjects performed by any of the authors.
Data Availability
Data sharing is not applicable to this article as no datasets were generated or analyzed during the current study.
Author information
Authors and Affiliations
Corresponding author
Additional information
Enhanced content
To view enhanced content for this article go to http://www.medengine.com/Redeem/0E87F0600231C044.
Rights and permissions
About this article
Cite this article
López, F., Williams, M.D., Skálová, A. et al. How Phenotype Guides Management of the Most Common Malignant Salivary Neoplasms of the Larynx?. Adv Ther 34, 813–825 (2017). https://doi.org/10.1007/s12325-017-0494-y
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12325-017-0494-y